Nonmagnetic Metal Nanoparticle Pathogen Detection via Voltammetry

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting pathogens in food and water samples are not sufficiently rapid or sensitive, particularly in underdeveloped countries and military deployments, where they pose health risks due to contamination.

Innovation Solution

A method involving the use of nonmagnetic metals, such as gold nanoshells, coupled with pathogen-specific antibodies to form complexes, which are then detected using voltammetry and magnetically separated to determine pathogen concentration, allowing for rapid and sensitive detection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional pathogen detection methods are used, then existing procedures can be maintained, but detection speed and sensitivity are insufficient

Engineering Contradiction:
Improvedetection sensitivityVSAvoiddetection time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent introduces nonmagnetic metal nanoparticles (such as gold nanoshells) as intermediary carriers that bind to pathogen-specific antibodies. These nanoparticles serve as detectable proxies that amplify the signal, enabling sensitive and rapid detection of pathogens without requiring direct observation of the pathogen itself. The nanoparticles mediate between the pathogen and the detection system, transforming a difficult detection problem into an easier measurement of metal nanoparticle presence.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the detection parameter from direct pathogen detection to nonmagnetic metal nanoparticle detection. By detecting the metal nanoparticles that bind to antibodies against the pathogen, the system transforms the detection target into a material with easily measurable properties (electrical conductivity, surface area), thereby achieving both high sensitivity and rapid detection results.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If nonmagnetic metal nanoparticles are introduced to enhance detection sensitivity, then pathogen detection capability improves, but sample complexity increases

Engineering Contradiction:
Improvedetection sensitivityVSAvoidsample processing complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent extracts and removes free nonmagnetic metal nanoparticles from the sample that did not bind to antibodies. This purification step isolates only the nanoparticles that are part of the antibody-pathogen complex, eliminating background noise and interference. By taking out the unwanted free nanoparticles, the system simplifies the sample for detection while maintaining high sensitivity.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent replaces complex mechanical separation methods with magnetic field-based separation. Although the nanoparticles themselves are nonmagnetic, they are attached to magnetic beads or particles that can be selectively separated using magnetic fields. This substitution of mechanical filtration or centrifugation with magnetic separation simplifies the overall process and improves reproducibility.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Measurement precision

If magnetic separation is used to isolate pathogen complexes, then detection accuracy improves, but operational complexity increases

Engineering Contradiction:
Improvedetection accuracyVSAvoidoperation simplicity
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The patent merges the nonmagnetic metal nanoparticles with magnetic beads or magnetic particles to form a hybrid complex. This combination allows the system to leverage both the detectable properties of nonmagnetic metals and the separable properties of magnetic materials. The merged complex can be easily manipulated and separated using magnetic fields, simplifying the operation while maintaining detection accuracy.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The magnetic beads act as intermediary carriers that facilitate the separation process. They bind to the nonmagnetic metal nanoparticles and antibody-pathogen complexes, enabling magnetic separation without requiring the nanoparticles themselves to be magnetic. This intermediary approach simplifies operation by providing a straightforward magnetic separation mechanism while preserving detection accuracy.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables rapid and sensitive detection of pathogens, capable of distinguishing between samples with and without pathogens, even at low concentrations, and can be automated for efficient use in remote locations.

Implementation Method 1

introducing a nonmagnetic metal into the sample that is coupled to an anti-pathogen antibody specific for the pathogen and configured to form a complex of the nonmagnetic metal and the pathogen

Methodology Applied
Scientific EffectBinding: Chemical Bonding

Implementation Method 2

magnetically separating immunocaptured complex from a remaining portion of the sample

Methodology Applied
Scientific EffectMagnetic separation: Magnetic Field

Implementation Method 3

detecting the presence of the nonmagnetic metal in the sample includes performing voltammetry on the electrode

Methodology Applied
Scientific EffectVoltammetry: Electrical Resistance

Data Source

PatentUS20230333103A1Biohazard analyzer
Publication Date: 2023.10.19 THE UNIV OF UTAH
  • US20230333103A1 patent drawing
  • US20230333103A1 patent drawing
  • US20230333103A1 patent drawing

AI summary

Detecting a pathogen may include introducing a nonmagnetic metal into the sample where the nonmagnetic metal includes an antibody that is specific to the pathogen to form a complex of the nonmagnetic metal and the pathogen, removing the nonmagnetic metal that is not complexed with the pathogen from the sample, and detecting the presence of the nonmagnetic metal in the sample where the presence of the nonmagnetic metal indicates the presence of the pathogen.